Clinical Trials Directory

Trials / Unknown

UnknownNCT02269046

Acupuncture and Moxibustion for Hyperlipemia

A Multi-center, Randomized, Stratified, Active-controlled Trial to Evaluate the Effects of Acupuncture and Moxibustion for Hyperlipidemias

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of 12 weeks of acupuncture and moxibustion compared with active control, on absolute and percent change from baseline in low-density lipoprotein cholesterol (LDL-C) among those with hyperlipidemia.

Conditions

Interventions

TypeNameDescription
OTHERacupuncture and moxibustionWarm needling acupuncture on Fenglong (ST40, bilateral), Zusanli (ST36, bilateral), Sanyinjiao (SP6, bilateral) and Cake-seperated moxibustion on Juque (RN14), Tianshu (ST25, bilateral), Pishu (BL20, bilateral), Xinshu (BL15, bilateral), Ganshu (BL18, bilateral), Shenshu (BL23, bilateral)
DRUGSimvastatin10mg/d,p.o,12 weeks.
OTHERTherapeutic Lifestyle Change* Reduced intakes of saturated fats (\<7% of total calories) and cholesterol (\<200 mg per day) * Therapeutic options for enhancing LDL lowering * Weight reduction * Increased physical activity

Timeline

Start date
2014-12-01
Primary completion
2016-12-01
Completion
2017-09-01
First posted
2014-10-20
Last updated
2014-10-20

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02269046. Inclusion in this directory is not an endorsement.